Magnetic Bead Extracellular Vesicle Isolation Without Centrifugation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for isolating exosomes and microvesicles are slow, tedious, subject to variability, and not suitable for scalability or automation, relying on centrifugation and other techniques that are inefficient and labor-intensive.

Innovation Solution

A method involving incubation of biological samples with particles that bind to surface markers, followed by contact with a high-density matrix and application of a magnetic or other force to translocate particle-microvesicle complexes, allowing for high-throughput isolation without centrifugation or washing steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If ultracentrifugation is used to isolate microvesicles, then isolation precision is improved, but productivity deteriorates and loss of time worsens

Engineering Contradiction:
Improveisolation precisionVSAvoidproductivity
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent replaces the mechanical ultracentrifugation system with a magnetic field-based separation system. Magnetic particles conjugated to antibodies bind to microvesicles, and a magnetic field is applied to separate the bound complexes from the sample, eliminating the need for high-speed centrifugation while maintaining isolation precision and enabling high-throughput processing

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces magnetic particles conjugated to antibodies as an intermediary between the microvesicles and the magnetic field. These particles serve as mediators that specifically bind to microvesicle surface markers and enable magnetic separation, replacing the direct mechanical force of ultracentrifugation with a targeted magnetic interaction

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If differential centrifugation is used to isolate microvesicles, then isolation precision is improved, but ease of operation deteriorates

Engineering Contradiction:
Improveisolation precisionVSAvoidease of operation
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent segments the complex multi-step centrifugation process into a single magnetic separation step. By using magnetic particles conjugated to specific antibodies, the method isolates microvesicles in one operation without requiring sequential centrifugation at different speeds, significantly simplifying the procedure while maintaining precision

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces the complex mechanical centrifugation sequence with a simpler magnetic field-based separation. The magnetic particles bound to microvesicles are easily separated by applying a magnetic field, eliminating the need for multiple centrifugation steps and making the procedure much easier to perform

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If existing isolation methods are used, then isolation precision is improved, but adaptability deteriorates

Engineering Contradiction:
Improveisolation precisionVSAvoidscalability
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent creates a universal magnetic separation platform that can isolate different types of microvesicles by simply changing the antibody conjugated to the magnetic particles. This single platform method works for various biofluids and target populations, enabling both high precision and easy adaptation to different research and diagnostic needs

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent enables adaptability by allowing changes in the antibody type, magnetic particle size, and magnetic field strength parameters. These parameter adjustments permit the same basic method to be optimized for different microvesicle populations and sample types, providing both precision and versatility

Inventive Principle:
Principle #35Parameter changes

4Manufacturing precision

If ultracentrifugation is used to isolate microvesicles, then isolation precision is improved, but loss of time worsens

Engineering Contradiction:
Improveisolation precisionVSAvoidloss of time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent replaces time-consuming ultracentrifugation with rapid magnetic separation. Magnetic particles bound to microvesicles are quickly separated by applying a magnetic field, reducing the isolation time from hours to minutes while maintaining high precision through specific antibody-microvesicle binding

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent performs preliminary binding of magnetic particles to microvesicles before separation. This pre-complex formation during incubation allows the actual separation step to be performed rapidly by magnetic field application, reducing the critical separation time while ensuring specific binding has already occurred

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient, scalable, and automatable isolation of microvesicles from multiple samples, facilitating the extraction of nucleic acids and proteins for diagnostic purposes.

Implementation Method 1

subjecting the at least one biological sample and the at least one high-density matrix to a magnetic field such that the at least one magnetic particle-microvesicle complex is translocated through the high-density matrix

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Data Source

PatentUS12493029B2Compositions, methods, and kits for the isolation of extracellular vesicles
Publication Date: 2025.12.09 EXACT SCIENCES CORP
  • US12493029B2 patent drawing
  • US12493029B2 patent drawing
  • US12493029B2 patent drawing

AI summary

The present disclosure relates to compositions, methods and kits for the isolation of extracellular vesicles. The compositions, methods and kits can comprise a high-density liquid reagent that facilitates the sequestration of extracellular vesicles bound to magnetic beads.